Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2010-04-19 | Antonius P. Schuh, Ph.D. 46 Chief Executive Officer of Sorrento Therapeutics, Inc. The Compensation Committee currently consists of directors Markin, Sklar and Schuh. Director Compensation Table shows Antonius P. Schuh received $9,396 in fees and $5,248 in option awards totaling $14,644. |
| 2011-04-18 | Antonius P. Schuh Age: 47 Chief Executive Officer of Sorrento Therapeutics, Inc. Director since 2009, term to expire 2014. Compensation: $22,500 fees earned or paid in cash, $2,065 option awards, total $24,565. Compensation Committee member. Excerpt: "Antonius P. Schuh 22,500 2,065 24,565 ... The Compensation Committee currently consists of directors Schuh, Markin and Patzig..." |
| 2013-04-25 | Antonius P. Schuh, Ph.D., Common Stock Director, Age 49, Chief Executive Officer of Trovagene, Inc., Director Since 2009, Term to Expire 2014. Member of Audit Committee and Compensation Committee. Director Summary Compensation Table shows $28,875 fees earned in cash and $32,127 option awards totaling $61,002. |
| 2013-12-24 | Antonius P. Schuh, Ph.D., Director. Includes 70,000 shares issuable upon the exercise of options. Compensation table shows $62,756 grant date fair value of awards. |
Data sourced from SEC filings. Last updated: 2026-03-05